Navigation Links
Yale test detects early stage ovarian cancer with 99 percent accuracy
Date:2/12/2008

Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.

Results of this new study are published in the February 15 issue of the journal Clinical Cancer Research. The results build on work done by the same Yale group in 2005 showing 95 percent effectiveness of a blood test using four proteins.

The ability to recognize almost 100 percent of new tumors will have a major impact on the high death rates of this cancer, said Mor. We hope this test will become the standard of care for women having routine examinations.

Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths in the United States and three times more lethal than breast cancer. It is usually not diagnosed until its advanced stages and has come to be known as the silent killer.

This new phase II clinical trial led by Gil Mor, M.D., associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, included 500 patients; 350 healthy controls and 150 ovarian cancer patients. Mor and colleagues validated the previous research and used a new platform called multiplex technology to simplify the test into one single reaction using very small amounts of serum from the blood. The new platform uses six protein biomarkers instead of four, increasing the specificity of the test from 95 to 99.4 percent. The team looked for the presence of specific proteins and quantified the concentration of those proteins in the blood.

The Early Detection Research Network (EDRN) of the National Cancer Institute (NCI) independently evaluated the results of the test.

This is the most sensitive and specific test currently available, said Mor. Previous tests recognized 15 to 20 percent of new tumors. Proteins from the tumors were the only biomarkers used to test for ovarian cancer. That is okay when you have big mass
'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Test Detects Sensitivity to HIV Drug
2. McMaster test detects the most prevalent respiratory viruses
3. CT colonography detects wide-range of extracolonic abnormalities in elderly patients
4. Blood protein detects lung cancer, even at earliest stage
5. New technique detects specific chromosomal damage, may indicate lung cancer risk
6. New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment
7. JCI online early table of contents: Feb. 7, 2008
8. New study suggests link between environmental toxins and early onset puberty in girls
9. A Reminder to Parents: Early Dental Visits Essential to Childrens Health
10. Rheumatoid arthritis sends many into early retirement
11. Early detection critical in treating pediatric thyroid cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Yale test detects early stage ovarian cancer with 99 percent accuracy
Yale test detects early stage ovarian cancer with 99 percent accuracy
(Date:1/7/2009)...Increase in Patients Unable to Pay Out-of-Pocket C...ng Hospital ERs , , SACRAMENTO, Calif., Jan. 7 ...ving a dramatic impact on California,s community h...port by the California Hospital Association (CHA)....ucted in November 2008 among hospital chief financ...
(Date:1/7/2009)...e Support and Convenience , , CARLSBAD, Calif., ...ch of a new on-line service for physicians and pat...rmation and products. The new Web site, www.skinm...ents and their physicians while offering the conve...(Photo: http://www.newscom.com/cgi-bin/prnh/2009...
(Date:1/7/2009)...ailure, slowed cell growth, study says , ,...drug used for many years to treat irregular heart ...ghting agent, researchers report. , Cancer cells n...ny of these cells are oxygen-deprived and need to ...xia-inducible factor (HIF-1), which help cells sur...
(Date:1/7/2009)...Foundation recently awarded two core faculty membe...ics a grant that will allow Drs. Gail Geller and C...ges health professionals face while caring for chi...uromuscular diseases (LTNMD). , The concept for t... international HeartSongs Project funded by the St...
Breaking Medicine News(10 mins):Health News:Economic Downturn Takes Toll on California Hospitals 2Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:Heart Drug May Be a Cancer Fighter 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3
...ible for Type 2 diabetes scientists have come clos.... The PSARL gene associated with the Type 2 diabe... Washington tomorrow. Diabetes, now considered as...100,000 Australians every year costing Australian ...
...cer-causing virus enables it to bypass immune syst...es an unusual gene and also ensures that the virus... function of a protein called HBZ, which is made b... 1 (HTLV-1), a retrovirus and a distant cousin to ...
...incidence of drug abuse in the 16 to 35 age group ...re unemployment is rampant, according to a study. ...ogical Study", released by Punjab Governor S F Rod...number of youth in the villages of Punjab were tak...
...start a health insurance policy next month which w...panies that fall under the Phase 1 category will b...eme // which will make the lowest paid the first t... Al Mazroui, Director General of the General Autho...
Other Medicine News:Health News:Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells 2Health News:Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells 3
(Date:1/7/2009)..., Late Preterm Infants Drive the Increase , ,.../ -- New government statistics confirm that the de... rate continues, putting more infants than ever at...to the March of Dimes. , , Nearly 543,000 babie...ional Center for Health Statistics, which today re...
(Date:1/7/2009)..., OXFORD, England, January 7 ...pany focused on allergy and critical care, today,...ts achieved in 2008 with,its ToleroMune(R) anti-a...patient recruitment for a further phase II clinica...way in Canada, has recruited 120 patients with con...
(Date:1/6/2009)..., NEW YORK, Jan. 6 Th...ut $2.7 million to four industry research teams fo...s for Parkinson,s disease. , , The funding was ...opment Initiative. This program, first launched i...orts on Parkinson,s research. TDI is part of MJF...
(Date:1/6/2009)..., PARIS, France, January 6 /PRNewswire-First... to Extend the Collaboration Until,December 2011 ...tion to Include Antibody,Discovery in Ophthalmolo...s to ExonHit if Allergan,Sublicenses to a Third P...LEHT) today announced a reinforcement,of its exis...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 1Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 2Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 3Thermage Inc Announces First Quarter 2008 Results Release Date and Conference Call 17826 1Clinical Update Debio 025 in Hepatitis C 1907 1Clinical Update Debio 025 in Hepatitis C 1907 2Clinical Update Debio 025 in Hepatitis C 1907 3NAMI 3A Women and Depression 3B 1 in 8 in Their Lifetime 3B Twice the Rate of Men 17822 1NAMI 3A Women and Depression 3B 1 in 8 in Their Lifetime 3B Twice the Rate of Men 17822 2
...S WIRE)--May 14, 2007 - Oculus Innovative,Sciences...cyn,Technology was the subject of a poster present... (EWMA) conference that was held in,Glasgow, Scotl... Results About an Antimicrobial,Solution in the Tr...ng & Harding infection criteria to evaluate th...
...-May 15, 2007 - Gemin X Biotechnologies,Inc. annou...Blood,demonstrated that its lead compound, obatocl...le Cell Lymphoma (MCL) cell lines and,primary cell...small,molecule specifically designed to inhibit al...validated cancer target, thus restoring,the natura...
Other Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...ttors , , Available with five different volume ra...ors can effectively meet the demands of any applic...nd superior functionality as our multichannel line...a wide range of liquid handling tasks including:,...
... high performance electronic pipetting!, Soft, f...educe hand fatigue and strain , Stress-free tip ...ding for easy volume identification , Accepts un...on AdvanTip Low Retention and AdvanTip Precision P...
... high performance electronic pipetting! , Soft, ...reduce hand fatigue and strain, Stress-free tip ...ing for easy volume identification, Accepts univ... AdvanTip Low Retention and AdvanTip Precision Pip...
The Finnpipette BioControl is a major step forward in electronic pipetting technology. A complete liquid handling system - with one universal handle and twelve interchangeable tip cone modules. All f
Medicine Products: